Lemborexant Tablets 2.5mg (Dayvigo® / デエビゴ錠2.5mg)

JPY ¥5,800

Japanese Insomnia Treatment Drug (Lemborexant 2.5mg). Oral film-coated tablet for treatment of insomnia, administered once daily immediately before bedtime. 100 tablets [10 tablets (PTP) x 10]. Mfd. by Eisai Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥5,336
10 - 19 12% JPY ¥5,104
20 + 18% JPY ¥4,756
SKU: DAY-2.5-TAB Category:

Description

Product Overview / 商品概要

Dayvigo Tablets 2.5mg (デエビゴ錠2.5mg)
Generic: Lemborexant / レンボレキサント
Therapeutic Category: Insomnia Treatment Drug / 不眠症治療薬
Manufactured by: Eisai Co., Ltd. / エーザイ株式会社

Composition & Specification / 組成・規格

Active Ingredient: Lemborexant 2.5mg per tablet / 1錠中 レンボレキサント 2.5mg
Additives: Titanium oxide, Iron sesquioxide, Magnesium stearate, Talc, Low-substituted hydroxypropylcellulose, Lactose hydrate, Hydroxypropylcellulose, Hypromellose, Macrogol 6000 / 酸化チタン、三二酸化鉄、ステアリン酸マグネシウム、タルク、低置換度ヒドロキシプロピルセルロース、乳糖水和物、ヒドロキシプロピルセルロース、ヒプロメロース、マクロゴール6000
Appearance: Dosage form: Film-coated tablet, Identification code: LEM 2.5, Color: Light red, Diameter: 7.1mm, Weight: 127mg, Thickness: 3.3mm
外観: 剤形: フィルムコーティング錠、識別コード: LEM 2.5、色: 淡赤色、直径: 7.1mm、質量: 127mg、厚さ: 3.3mm

Indications / 効能効果

EN: Insomnia
JA: 不眠症

Dosage and Administration / 用法用量

EN: The usual adult dose is lemborexant 5mg once daily, administered orally immediately before bedtime. The dose may be adjusted according to symptoms, but must not exceed 10mg once daily.
JA: 通常、成人にはレンボレキサントとして、1回1日5mgを就寝直前に経口投与する。なお、症状により適宜増減するが、1回1日10mgを超えないこととする。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product; patients with severe hepatic impairment
JA: 本剤の成分に対し過敏症の既往歴のある患者、重度の肝機能障害のある患者

Regulatory Information / 規制情報

Approval No.: 30200AMX00017000
Sales Started: July 2020 / 2020年7月
Classification Code: 87119
Storage: Store at room temperature / 室温保存
Shelf Life: 5 years / 5年

Packaging / 包装

Main Package (for sale): 100 tablets [10 tablets (PTP) x 10] / 100錠 [10錠(PTP)×10]
Other Available Packages (by special order): 100 tablets [10 tablets (PTP) x 10], 100 tablets [Bottle, bulk]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Lemborexant Tablets 2.5mg (Dayvigo® / デエビゴ錠2.5mg)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Lemborexant Tablets 2.5mg (Dayvigo®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.